Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) valuation · P/E 40, rev $3.02B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) P/E 40, rev $3.02B.
| Metric | Value |
|---|---|
| P/E | 40 |
| Market cap | $5.19B |
| Revenue | $3.02B |
| P/S | 1.7 |
| P/B | 105.4 |
AMRX valuation FAQ
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trailing P/E is 40 on the latest cached fundamentals snapshot.
What is AMRX's market cap?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) market cap is $5.19B on the latest cached fundamentals snapshot.
What is AMRX's latest revenue?
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue was $3.02B. Statements: https://lician.com/financials/amrx
What is AMRX's price-to-sales ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) price-to-sales (P/S) is 1.7, cached market cap $5.19B divided by revenue $3.02B.
What is AMRX's price-to-book ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) price-to-book (P/B) is 105.4 on the latest cached fundamentals snapshot.
How many AMRX valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX): P/E, Market cap, Revenue, P/S, and P/B.
Where is AMRX valuation listed?
Cached valuation multiples for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) are listed at https://lician.com/valuation/amrx.
Not investment advice. Cached rows, not a live tape.